Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Author

Nan-Bin Liu

h-index 3 View on Semantic Scholar

We have 4 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma

KANSL2 is identified as a key regulator of tumor progression and immune remodeling in LIHC and represents a promising biomarker for diagnosis and prognosis, and a potential therapeutic target.

Nan-Bin Liu, Kun Li, Jun-Qiao Feng et al. · 0 citations
Open access Jul 2026

BUB3: a novel prognostic biomarker and therapeutic target in hepatocellular carcinoma unveiled by pan-cancer analysis and experimental validation

It is demonstrated that BUB3 plays a critical role in tumor progression and immune regulation and possesses substantial diagnostic and prognostic value, highlighting its potential as both a biomarker for patient stratification and a promising therapeutic target across multiple cancer types.

Xiaona Liu, Yajie Qi, Xinyi Dang et al. · 0 citations
Open access Aug 2026

Integrative multi-omics and experimental validation reveal the oncogenic role of DDX52 in liver hepatocellular carcinoma.

Integrative analyses and experimental validation suggest that DDX52 is a potential prognostic biomarker and therapeutic target in LIHC and its associations with immune features and multiple cancer-related pathways provide hypotheses for future mechanistic investigation.

Chong-Yu Zhang, Qian-Kun Wang, Mengchen Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.